. Author manuscript; available in PMC: 2014 Dec 10.

Published in final edited form as: Biol Blood Marrow Transplant. 2011 Feb 18;17(10):1490–1496. doi: 10.1016/j.bbmt.2011.02.007

Table 1.

Pretransplant patient characteristics

Characteristic		Number (%)
Gender	Male	49 (62)
Gender	Female	30 (38)
Age	>58	40 (51)
Age	≤58	39 (49)
Disease	AML	63 (80)
Disease	MDS	16 (20)
Disease status at time of allo-SCT	CR	42 (53)
	CR1	25 (32)
	CR2	17 (22)
	Active disease	37 (47)
Cytogenetics	Good risk	4 (5)
	Intermediate risk	50 (63)
	Poor risk	20 (25)
	Unknown	5 (6)
Graft received	Related Donor	41 (52)
Graft received	Unrelated Donor	38 (48)
Stem cell source	Bone marrow	38 (48)
Stem cell source	Peripheral blood	41 (52)
HCT-CI Score^*	≤ 1	41 (52)
	2	9 (11)
	≥3	27 (34)

Percentages listed are of the total number of patients (n=79).

Data were unavailable for 2 patients.

AML indicates acute myeloid leukemia; MDS, myelodysplastic syndrome; allo-SCT, allogeneic stem cell transplantation; CR, complete remission; CR1, first complete remission; CR2, second complete remission; HCT-CI, hematopoietic stem cell transplantation comorbidity index(19).